CLINICAL OUTCOMES IN NON-INHIBITOR SEVERE HAEMOPHILIA A PATIENTS RECEIVING PROPHYLAXIS ACROSS CURRENTLY AVAILABLE HAEMOPHILIA A TREATMENTS: INSIGHTS FORM THE 'COST OF HAEMOPHILIA: A SOCIOECONOMIC SURVEY III' (CHESS III) STUDY

被引：0
|
作者：
Blenkiron, T. [1 ]
Hinds, D. [2 ]
Santos, S. [3 ]
Burke, T. [4 ]
Grazzi, Ferri E. [5 ]
机构：
[1] HCD Econ, Innovat Ctr, Daresbury, England
[2] BioMarin Pharmaceut Inc, Oakland, CA USA
[3] BioMarin Pharmaceut Inc, London, England
[4] HCD Econ, Warrington, Cheshire, England
[5] HCD Econ, Daresbury, Chw, England
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD63
引用
下载
收藏
页码：S516 / S516
页数：1
相关论文
共 5 条
  • [1] Exploring baseline characteristics, treatment decisions and patient-centred outcomes of people with severe haemophilia A receiving prophylaxis: Early findings from the multi-country 'Cost of Haemophilia: A Socioeconomic Survey III' (CHESS III) study
    Chowdary, Pratima
    Polito, Letizia
    Chafaie, Romain
    Moreno, Katya
    Blenkiron, Tom
    Burke, Tom
    Grazzi, Enrico Ferri
    HAEMOPHILIA, 2024, 30 : 165 - 167
  • [2] Clinical and Humanistic Burden of Non-inhibitor Haemophilia A in Five European Countries: Insights from the CHESS II Study
    Ferri Grazzi, Enrico
    Becker, Tobias
    Brandt, Stephanie
    Duport, Gaetan
    Garcia Diego, Daniel-Anibal
    Lupi, Angelo
    McKeown, William
    Morgan, Debra
    Camp, Charlotte
    Hawes, Charles
    Blenkiron, Tom
    O'Hara, Jamie
    Burke, Tom
    ADVANCES IN THERAPY, 2024, 41 (10) : 3888 - 3904
  • [3] THE ECONOMIC BURDEN OF SEVERE HAEMOPHILIA A WITHOUT INHIBITORS AMONG ADULTS WITH HEALTH INSURANCE COVERAGE IN THE UNITED STATES: INSIGHTS FROM THE "COST OF HAEMOPHILIA ACROSS THE US: A SOCIOECONOMIC SURVEY" CHESS US AND CHESS US plus STUDIES
    Grazzi, Ferri E.
    Blenkiron, T.
    O'Hara, J.
    Chen, E.
    Hinds, D.
    Burke, T.
    VALUE IN HEALTH, 2022, 25 (07) : S339 - S339
  • [4] REAL-WORLD CLINICAL OUTCOMES IN PEOPLE FROM ACROSS EUROPE WITH SEVERE HAEMOPHILIA B RECEIVING FIX PROPHYLAXIS: AN ANALYSIS OF CHESS II
    Burke, T.
    Asghar, S.
    O'Hara, J.
    Chuang, M.
    Sawyer, E.
    Li, N. N.
    HAEMOPHILIA, 2021, 27 : 115 - 115
  • [5] Prospective, observational, 2-cohort study of adult patients with severe haemophilia A in Greece. Cost, clinical outcomes and quality of life comparison between on demand and secondary prophylaxis treatment strategies (HAMLET)
    Kouramba, A.
    Kotsi, P.
    Akianidis, V.
    Varaklioti, A.
    Katsarou, O.
    HAEMOPHILIA, 2019, 25 : 47 - 47
1